Cargando…
Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease
Diabetic kidney disease (DKD) is a widespread chronic microvascular complication of diabetes mellitus (DM), affects almost 30–50% of patients, and represents a leading cause of death of DM. Serotonin or 5-hydroxytryptamine (5-HT) is a multifunctional bioamine that has crucial roles in many physiolog...
Autores principales: | Yang, Yu, Huang, Hui, Xu, Zheng, Duan, Jun-kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591914/ https://www.ncbi.nlm.nih.gov/pubmed/28929122 http://dx.doi.org/10.1155/2017/7680576 |
Ejemplares similares
-
Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity
por: Oh, Chang-Myung, et al.
Publicado: (2016) -
The Serotonin-6 Receptor as a Novel Therapeutic Target
por: Yun, Hyung-Mun, et al.
Publicado: (2011) -
Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment
por: Lee, Ansoo, et al.
Publicado: (2022) -
Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
por: Pak, Eun Seon, et al.
Publicado: (2022) -
Serotonin and catecholaminergic polymorphic ventricular tachycardia: a possible therapeutic role for SSRI s?
por: CHEN, SHUNJUAN, et al.
Publicado: (2010)